UNSPSC 51373306: Acetaminophen/butalbital/caffeine/hydrocodone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373306 Acetaminophen/butalbital/caffeine/hydrocodone is a Commodity code that in recent state and local procurement activity maps to a broader pharmaceutical supply category—naloxone and drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products—rather than the specific opioid-analgesic combination the code nominally names. State and local issuers soliciting under this code include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), and cooperative purchasing alliances serving multiple state and local jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance). The work encompasses procurement of finished pharmaceutical products and related medical supplies for distribution through county health facilities, state pharmacy benefit programs, and cooperative purchasing networks serving state agencies and local government entities. Solicitation types include IFB for direct product purchase, RFI for market intelligence on direct-to-manufacturer prescription programs, and RFP for multi-vendor pharmaceutical supply contracts under cooperative purchasing agreements.

Recent activity appears concentrated in the South and Midwest. Seminole County posted IFB 60459723LAS on June 30, 2026 (due July 26, 2023, though the posted date creates a temporal inconsistency in the record) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its community health building in Sanford, Florida. Texas HHS issued RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a direct-to-manufacturer prescription program serving the state's pharmacy benefit system. Minnesota Multistate Cooperative Purchasing Alliance, administered by the Minnesota Department of Administration, released RFP S1070000015802 on January 20, 2026 (response deadline March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be supplied through authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) and distributed across participating state and local government facilities in Minnesota and Oregon, with contract effectiveness July 1, 2026 and a two-year initial term.